Lupine Publishers-Journal of Hepatology Research


Advanced Hepatocellular Carcinoma in A ScottishPopulation – Current Experience and the Future by Baxter MA in Current Trends in Gastroenterologyand Hepatology in Lupine Publishers

Sorafenib is the current first line standard of care in patients with advanced hepatocellular carcinoma (HCC). Several other drugs are emerging as efficacious agents in this setting. This article will outline our current real-world experience with sorafenib in a Scottish population as well as discuss the evidence behind new potential therapies in Lupine Publishers.

For more information, please go through the below links

https://lupinepublishers.com/gastroenterology-hepatology-journal/fulltext/advanced-hepatocellular-carcinoma-in-a-scottish-population-current-experience-and-the-future.ID.000112.php

https://lupinepublishers.com/gastroenterology-hepatology-journal/pdf/CTGH.MS.ID.000112.pdf

https://lupinepublishers.com/gastroenterology-hepatology-journal/abstracts/advanced-hepatocellular-carcinoma-in-a-scottish-population-current-experience-and-the-future.ID.000112.php

For more Lupine Publishers Open Access Journals Please visit our website:http://www.lupinepublishers.com/


Comments

Popular posts from this blog

Lupine Publishers-Journal of Clinical Gastroenterology and Hepatology

Lupine Publishers - Journals of Gastroenterology and Hepatology

Lupine Publishers-Gastroenterology open access journal